RECIPES · Project

Decision Tools for Companies Navigating EU Precautionary Rules and Innovation

otherPrototypeTRL 3Thin data (2/5)

Imagine you've developed a promising new product — say a food additive or a chemical — but regulators block it "just in case" it might be harmful, even without solid proof. That's the precautionary principle in action, and it's been a headache for businesses across Europe for decades. RECIPES brought together lawyers, social scientists, and policymakers from 7 countries to study 8 real cases where precaution clashed with innovation, then built practical assessment tools so decision-makers can weigh risks without automatically killing new ideas. Think of it as a rulebook for "how to be careful AND keep innovating."

By the numbers

Real-world case studies of precautionary principle application

Countries where precautionary principle application was examined

Consortium partners across the project

Countries represented in the consortium

Total project deliverables produced

The business problem

What needed solving

Companies launching innovative products in the EU — especially in chemicals, food, biotech, and environmental technology — frequently face regulatory delays or outright blocks when the precautionary principle is invoked. The lack of clear, consistent criteria for how precaution is applied across different countries and sectors creates uncertainty, increases compliance costs, and slows time-to-market. Businesses need structured ways to anticipate and address precautionary objections without abandoning responsible innovation.

The solution

What was built

The project produced 15 deliverables including policy brief concepts and dialogue formats, a multi-case study analysis framework covering 8 real-world cases across 5 countries, and multi-criteria assessment plans and materials for weighing precaution against innovation on a case-by-case basis. These are decision-support tools aimed at policymakers and regulatory bodies.

Audience

Who needs this

Regulatory affairs consultancies advising on EU market accessChemical and biotech companies facing precautionary restrictionsFood technology firms navigating novel food approvalsIndustry associations lobbying on precautionary principle reformLaw firms specializing in EU regulatory and environmental law

Business applications

Who can put this to work

Regulatory affairs consulting

SME

Target: Regulatory strategy firms advising companies on EU market access

If you are a regulatory affairs consultancy helping clients get products approved in the EU — this project developed multi-criteria assessment tools and case-study-based guidance covering 8 real-world precautionary principle cases across 5 countries. These tools can strengthen your advisory services by providing structured methods to anticipate and navigate precautionary objections before they stall your clients' product launches.

Chemicals and advanced materials

enterprise

Target: Chemical companies facing REACH or other precautionary restrictions

If you are a chemical manufacturer dealing with products flagged under precautionary regulations — this project analyzed how the precautionary principle is applied across international treaties and EU-level policy, producing policy briefs and scenario tools. These can help your regulatory team build more effective dossiers that address precautionary concerns while demonstrating responsible innovation.

Agri-food and biotechnology

mid-size

Target: Biotech or food tech firms launching products in regulated EU markets

If you are a food tech or biotech company struggling with slow EU approvals due to precautionary restrictions — this project created co-designed tools for policymakers to assess risks and uncertainty on a case-by-case basis, drawing from 8 detailed case studies. Understanding these tools and the reasoning behind precautionary decisions can help you shape stronger regulatory submissions and engage more effectively with authorities.

Frequently asked

Quick answers

How much would it cost to access these tools and assessments?

The project was publicly funded EU research (RIA), so its deliverables — including policy briefs, case study analyses, and assessment materials — are publicly available through the project website. There are no licensing fees for the research outputs themselves.

Can these tools work at industrial scale across multiple product lines?

The tools were designed for policy-level decision-making, not for high-volume industrial screening. They are best suited for strategic regulatory planning on a case-by-case basis, as the project explicitly aimed at case-by-case precautionary assessments. Adapting them into scalable compliance workflows would require additional development.

Is there any IP or licensing involved?

As a publicly funded Research and Innovation Action, the project outputs are generally open access. The 15 deliverables including policy briefs and assessment materials are available through CORDIS and the project website. No commercial patents are indicated.

How does this help with actual EU regulatory submissions?

The project produced multi-criteria assessment plans, policy briefs, and scenario analyses based on 8 real case studies across 5 countries. These provide structured reasoning frameworks that can inform how companies frame risk arguments in regulatory filings, though they are not a substitute for formal regulatory dossiers.

What's the timeline to implement these insights in my company?

The assessment tools and case study findings are immediately accessible since the project closed in June 2022. However, translating policy-level tools into company-specific regulatory strategy would require adaptation work with your legal and regulatory teams. The project materials serve as a knowledge base, not a plug-and-play solution.

Who developed these tools — are there industry practitioners involved?

The consortium of 11 partners across 7 countries was heavily research-oriented, with 7 research organizations and 3 universities. Only 1 industry partner participated, and the consortium included 2 SMEs. This means the tools reflect strong academic and policy expertise but limited direct industry input.

Consortium

Who built it

The RECIPES consortium of 11 partners spanning 7 countries (AT, BG, DE, DK, IT, NL, NO) is overwhelmingly academic and research-driven: 7 research organizations and 3 universities, with just 1 industry partner and 2 SMEs (9% industry ratio). Led by Universiteit Maastricht in the Netherlands, this composition is typical of policy research projects and signals deep expertise in legal and social science analysis. For a business looking to leverage these outputs, the low industry involvement means the tools were designed with policymakers in mind, not commercial users — so expect a translation gap between the research outputs and practical business application.

UNIVERSITEIT MAASTRICHTCoordinator · NL
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAWparticipant · NL
APPLIED RESEARCH AND COMMUNICATIONS FUNDparticipant · BG
DIALOGIK GEMEINNUTZIGE GESELLSCHAFT FUR KOMMUNIKATIONS UND KOOPERATIONSFORSCHUNG MBHparticipant · DE
GFZ HELMHOLTZ-ZENTRUM FUR GEOFORSCHUNGparticipant · DE
FONDEN DEMOCRACY Xparticipant · DK
HUMBOLDT-UNIVERSITAET ZU BERLINparticipant · DE
CONOSCENZA E INNOVAZIONE SOCIETA ARESPONSABILITA LIMITATA SEMPLIFICATAparticipant · IT
OESTERREICHISCHE AKADEMIE DER WISSENSCHAFTENparticipant · AT
UNIVERSITETET I BERGENparticipant · NO
ECOLOGIC INSTITUT GEMEINNUTZIGE GMBHparticipant · DE

How to reach the team

The coordinator is Universiteit Maastricht (Netherlands). Contact details can be found through the university's research department or the project website.

Order a report on this consortium See UNIVERSITEIT MAASTRICHT profile →

Next steps

Talk to the team behind this work.

Want to understand how EU precautionary principle research could inform your regulatory strategy? SciTransfer can connect you with the RECIPES research team and help translate their findings into actionable guidance for your market access challenges.

Order a report on this topic More in other